In the last trading session, 5.25 million shares of the Clover Health Investments Corp (NASDAQ:CLOV) were traded, and its beta was 1.92. Most recently the company’s share price was $2.83, and it changed around -$0.09 or -3.08% from the last close, which brings the market valuation of the company to $1.44B. CLOV currently trades at a discount to its 52-week high of $4.87, offering almost -72.08% off that amount. The share price’s 52-week low was $1.01, which indicates that the current value has risen by an impressive 64.31% since then. We note from Clover Health Investments Corp’s average daily trading volume that its 10-day average is 5.04 million shares, with the 3-month average coming to 5.70 million.
Clover Health Investments Corp stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended CLOV as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Instantly CLOV has showed a red trend with a performance of -3.08% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.05 on recent trading dayincreased the stock’s daily price by 7.21%. The company’s shares are currently down -10.16% year-to-date, but still down -5.35% over the last five days. On the other hand, Clover Health Investments Corp (NASDAQ:CLOV) is -20.28% down in the 30-day period. We can see from the shorts that 20.44 million shares have been sold at a short interest cover period of 3.19 day(s).
The consensus price target as assigned by Wall Street analysts is $2.5, which translates to bulls needing to decrease their stock price by -13.2% from its current value. Analyst projections state that CLOV is forecast to be at a low of $1.8 and a high of $6.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -237.67%.
CLOV Dividends
Clover Health Investments Corp’s next quarterly earnings report is expected to be released on 2025-May-05.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.92% of Clover Health Investments Corp shares, and 26.16% of them are in the hands of institutional investors. The stock currently has a share float of 27.23%. Clover Health Investments Corp stock is held by 245.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.5581% of the shares, which is about 17.35 million shares worth $21.33 million.
RENAISSANCE TECHNOLOGIES LLC, with 2.3123% or 11.27 million shares worth $13.86 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
